Treatment of hi-virus infections with oxidised blood proteins
CA 2523357 C · Owner: Hamburger Stiftung Zur Foerderung Von Wissenschaft Und Kultur · Inventors: Kehrel, Beate
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to medicaments for the treatment of an infection of a host cell by HI-viruses and/or for the inhibition of the binding of an Env protein to a CD4 protein. Medicaments are disclosed for the above containing , oxidised proteins, oxidised peptides and/or oxidised peptides obtainable from , full blood, production methods for such medicaments and therapeutic and nontherapeutic applications of said medicaments.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 25, 2003 and granted July 14, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.